MedMira receives Health Canada approval for its Multiplo(R) …
6 days ago · HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo ...
MedMira Inc. Receives Health Canada Approval for Its Multiplo(R) …
6 days ago · MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps.
Health Canada approves MedMira’s rapid test for HIV and syphilis
4 days ago · MedMira CEO Hermes Chan said: "Our Multiplo TP/HIV device is the fastest testing solution for HIV-1/2 and Syphilis and has been used in various settings and markets (such as in Europe, Colombia ...
MedMira Inc. (MMIRF) Latest Stock News & Headlines - Yahoo Finance
Get the latest MedMira Inc. (MMIRF) stock news and headlines to help you in your trading and investing decisions.
MedMira Gains Health Canada Approval for Rapid Test
MedMira Inc. has received approval from Health Canada for its Multiplo Rapid TP/HIV Test, a crucial tool for addressing the health crises of HIV and syphilis in Canada. This rapid test, which provides immediate results using a simple finger prick, is expected to significantly impact the healthcare system by offering a fast and cost-effective ...
MedMira Inc. (MIR.V) Latest Stock News & Headlines - Yahoo …
Get the latest MedMira Inc. (MIR.V) stock news and headlines to help you in your trading and investing decisions.
MedMira Expands Market with Strategic Approvals
Nov 29, 2024 · MedMira Inc. has reported progress in expanding its market presence and securing regulatory approvals. The company received FDA approval for its HIV test and is awaiting further approvals for its...
MIR.V - | Stock Price & Latest News | Reuters
Nov 28, 2024 · MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease...
MedMira erhält von Health Canada Zulassung für den Multiplo(R) …
4 days ago · Halifax, Nova Scotia - 24. Dezember 2024 - MedMira Inc. (MedMira) (TSXV: MIR) gab heute bekannt, dass es am 24. Dezember 2024 von Health Canada die Zulassung für seinen Multiplo TP/HIV-Schnelltest
Medmira Inc (MMIRF) News Headlines - Nasdaq
Here you can find up-to-the-minute news and analysis of the company that you are researching for potential investment opportunities.